Remedent Inc logo

REMI - Remedent Inc Share Price

$0.151 0.0  0.0%

Last Trade - 04/03/21

Sector
Healthcare
Size
Micro Cap
Market Cap £2.18m
Enterprise Value £2.18m
Revenue £816k
Position in Universe 6454th / 6651
Bullish
Bearish
Unlock REMI Revenue
Momentum
Relative Strength (%)
1m -30.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -64.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
3.62 2.77 2.36 2.70 1.60 1.06 -21.7%
-79.9 +52.9 -79.2
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, Remedent, Inc. revenues increased 8% to $879K. Net income totaled$100K vs. loss of $499K. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Net Income reflects Equity(loss) income from investments increase from $202K(expense) to $24K (income), Sales and marketing decrease of72% to $83K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

REMI Revenue Unlock REMI Revenue

Net Income

REMI Net Income Unlock REMI Revenue

Normalised EPS

REMI Normalised EPS Unlock REMI Revenue

PE Ratio Range

REMI PE Ratio Range Unlock REMI Revenue

Dividend Yield Range

REMI Dividend Yield Range Unlock REMI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
REMI EPS Forecasts Unlock REMI Revenue
Profile Summary

Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.

Directors
Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated July 31, 1986
Public Since November 16, 1993
No. of Shareholders: n/a
No. of Employees: 16
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 19,995,969
Free Float (0.0%)
Eligible for
ISAs
SIPPs
REMI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for REMI
Upcoming Events for REMI
Frequently Asked Questions for Remedent Inc
What is the Remedent Inc share price?

As of 04/03/21, shares in Remedent Inc are trading at $0.151, giving the company a market capitalisation of £2.18m. This share price information is delayed by 15 minutes.

How has the Remedent Inc share price performed this year?

Shares in Remedent Inc are currently trading at $0.151 and the price has moved by -20.53% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Remedent Inc price has moved by -37.98% over the past year.

What are the analyst and broker recommendations for Remedent Inc?

There are no analysts currently covering Remedent Inc.

When will Remedent Inc next release its financial results?

Remedent Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Remedent Inc dividend yield?

Remedent Inc does not currently pay a dividend.

Does Remedent Inc pay a dividend?

Remedent Inc does not currently pay a dividend.

When does Remedent Inc next pay dividends?

Remedent Inc does not currently pay a dividend.

How do I buy Remedent Inc shares?

To buy shares in Remedent Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Remedent Inc?

Shares in Remedent Inc are currently trading at $0.151, giving the company a market capitalisation of £2.18m.

Where are Remedent Inc shares listed? Where are Remedent Inc shares listed?

Here are the trading details for Remedent Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: REMI
What kind of share is Remedent Inc?

Based on an overall assessment of its quality, value and momentum, Remedent Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Remedent Inc share price forecast 2021?

We were not able to load any forecast data for Remedent Inc.

How can I tell whether the Remedent Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Remedent Inc. Over the past six months, the relative strength of its shares against the market has been -6.47%. At the current price of $0.151, shares in Remedent Inc are trading at -19.76% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Remedent Inc PE Ratio?

We were not able to find PE ratio data for Remedent Inc.

Who are the key directors of Remedent Inc?

Remedent Inc's management team is headed by:

Guy De Vreese - CHM
Philippe Van Acker - CFO
Fred Kolsteeg - IND
Who are the major shareholders of Remedent Inc?

Here are the top five shareholders of Remedent Inc based on the size of their shareholding:

De Vreese (Guy) Individual Investor
Percentage owned: 23.17% (4.63m shares)
Sternberg (Stuart L) Individual Investor
Percentage owned: 12.67% (2.53m shares)
Kolsteeg (Frederick) Individual Investor
Percentage owned: 0.48% (95.0k shares)
Similar to REMI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.